netFormulary South East London Joint Medicines Formulary NHS
Guy's and St Thomas' NHS Foundation Trust
Kings College Hospital NHS Foundation Trust
Lewisham and Greenwich NHS Trust
 Formulary Chapter 3: Respiratory system - Full Section

03.01 Bronchodilators
03.01.01 Adrenoceptor agonists Selective Beta2 agonists
Short-acting beta2 agonists
Long-acting beta2 agonists Other adrenoceptor agonists
03.01.02 Antimuscarinic bronchodilators
Short Acting Anti-muscarinic Bronchodilators
Long Acting Anti-muscarinic Bronchodilators
03.01.03 Theophylline
03.01.04 Compound bronchodilator preparations
03.01.05 Peak flow meters, inhaler devices and nebulisers
Peak flow meters
Drug delivery devices
03.02 Corticosteroids
03.02.01 Inhaled Corticosteroids
03.02.02 Combination products (ICS+LABA) for asthma
03.02.03 Combination products (ICS+LABA) for COPD
03.03 Cromoglicate, related therapy and leukotriene receptor antagonists
03.03.01 Cromoglicate and related therapy
03.03.02 Leukotriene receptor antagonists
03.03.03 Phosphodiesterase type-4 inhibitors
03.04 Antihistamines, hyposensitisation, and allergic emergencies
03.04.01 Antihistamines
Non-sedating antihistamines
Sedating antihistamines
03.04.02 Allergen Immunotherapy
Omalizumab, mepolizumab and other therapies
03.04.03 Allergic emergencies
03.04.04 Management of urticaria
03.05 Respiratory stimulants and pulmonary surfactants
03.05.01 Respiratory stimulants
03.05.02 Pulmonary surfactants
03.06 Oxygen
03.07 Mucolytics
Dornase alfa
Hypertonic Sodium Chloride
03.08 Aromatic inhalations
03.09 Cough preparations
03.09.01 Cough suppressants
Palliative care
03.09.02 Expectorant and demulcent cough preparations
03.10 Systemic nasal decongestants
03.11 Antifibrotics
03.12 Miscellaneous preparations
03.13 Triple combination therapy inhalers (ICS + LABA + LAMA) for adults with COPD
03.14 Immunomodulatory agents in respiratory disease